Morning Briefing
Summaries of health policy coverage from major news organizations
Large Trial Of Tenofovir Gel For Women Set To Begin In South Africa
A 24-month clinical trial looking at the effectiveness of tenofovir gel use among women to reduce the risk of HIV infection is set to begin in South Africa in late July or early August, the Mail & Guardian reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
